Home Others Other inhibitor 4-Methylumbelliferone (4-MU) For research use only.

4-Methylumbelliferone (4-MU)

4-Methylumbelliferone is a hyaluronic acid (HA) synthesis inhibitor with an IC50 of 0.4 mM.

4-Methylumbelliferone (4-MU) Chemical Structure

4-Methylumbelliferone (4-MU) Chemical Structure

CAS: 90-33-5

Selleck's 4-Methylumbelliferone (4-MU) has been cited by 5 publications

Purity & Quality Control

Batch: Purity: 99.89%
99.89

4-Methylumbelliferone (4-MU) Related Products

Cell Data

Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
COS1 cells Function assay Agonistic activity was determined in COS1 cells transfected with GAL 4-PPAR gamma receptor, EC50=0.021 μM 12617924
CV-1 cells Function assay Maximal reporter activity against human Peroxisome proliferator activated receptor gamma Gal4 chimeric in transiently transfected CV-1 cells by functional assay, EC50=0.043 μM 11720854
COS-1 cells Function assay In vitro transactivation of human peroxisome proliferator activated receptor gamma measured in PPAR-GAL4 chimeric COS-1 cells, EC50=0.02 μM 12873517
CV-1 cells Function assay Activation of peroxisome proliferator activated receptor gamma measured by induction of 50% of maximum alkaline phosphatase activity, transfection assay in CV-1 cells, EC50=0.08913 μM 9836620
CV-1 cells Function assay In vitro transcriptional activation of Peroxisome proliferator activated receptor gamma (PPAR) expressed in CV-1 cells, EC50=0.06 μM 8576907
COS-1 cells Function assay In vitro agonist activity tested for transactivation in human PPAR gamma-Gal4 chimeric COS-1 cells, EC50=0.02 μM 12729668
CV-1 cells Function assay In vitro evaluation against RXR-alpha/PPAR-gamma in CV-1 cells by cotransfection assay was determined, EC50=0.325 μM 12954061
HepG2 cells Function assay Effective concentration against human PPARgamma expressed in HepG2 cells, EC50=0.039 μM 16107150
Huh7 cells Function assay Functional activity at human PPAR gamma in Huh7 cells by transactivation assay, EC50=0.22 μM 16366601
Huh7 cells Function assay Effect on PPAR gamma transactivation activity in Huh7 cells, EC50=0.22 μM 16451087
U2OS cells Function assay Effect on PPARgamma transactivation activity in U2OS cells, EC50=0.03 μM 16300944
CV1 cells Function assay Transactivation of PPARgamma in CV1 cells, EC50=0.076 μM 16821769
human keratinocytes Proliferation assay Antiproliferative activity against human keratinocytes, EC50=8 μM 16821769
HT29 cell Proliferation assay Antiproliferative activity against human HT29 cell line, EC50=45 μM 16821769
NIH3T3 cells Function assay Activity at human PPAR gamma transfected in NIH3T3 cells by luciferase activity assay, EC50=0.32 μM 16854085
CV1 cells Function assay Transactivation of human PPARgamma in CV1 cells by luciferase reporter gene assay, EC50=0.308 μM 16970391
Huh7 cells Function assay Activity at human PPAR gamma in Huh7 cells by transactivation assay, EC50=0.22 μM 17034149
HepG2 cells Function assay Agonist activity at human PPAR gamma in a HepG2 cells by PPAR-GAL4 transactivation assay, EC50=0.158 μM 16973358
HepG2 cells Function assay Agonist activity at human PPAR gamma in HepG2 cells by PPAR-GAL4 transactivation assay, EC50=0.158μM 16979341
CV1 cells Function assay Activity at human PPARgamma in CV1 cells, EC50=0.308 μM 17005394
HEK293 cells Function assay Activity at human adipose tissue PPAR gamma expressed in HEK293 cells by PPAR-GAL4 transactivation assay, EC50=0.31 μM 17343371
rat L6 cells Function assay Effect on fatty acid oxidation in rat L6 cells, EC50=5 μM 17343371
HepG2 cells Function assay Agonist activity at human PPARgamma in HepG2 cells by PPAR-GAL4 transactivation assay, EC50=0.082 μM 17157019
CV1 cells Function assay Agonist activity at human PPARalpha in CV1 cells by GAL4 transactivation assay after 24 hrs, EC50=3.46 μM 17507225
CV1 cells Function assay Agonist activity at human PPARgamma in CV1 cells by GAL4 transactivation assay after 24 hrs, EC50=0.03 μM 17507225
CV1 cells Function assay Agonist activity at human PPARgamma expressed in CV1 cells by receptor transactivation assay, EC50=0.308 μM 18029178
CV1 cells Function assay Agonist activity at PPARgamma in CV1 cells by transactivation assay, EC50=0.308 μM 17129725
HEK293 cells Function assay Agonist activity at PPARgamma receptor expressed in HEK293 cells by GAL4 transactivation assay, EC50=0.035 μM 17292606
NIH3T3 cells Function assay Agonist activity at human PPARgamma expressed in NIH3T3 cells by GAL4 transactivation assay, EC50=0.32 μM 17624777
HEK293 cells Function assay Agonist activity at PPARgamma expressed in HEK293 cells by GAL4 transactivation assay, EC50=0.19 μM 18029176
HEK293 cells Function assay Agonist activity at PPARgamma expressed in HEK293 cells assessed as aP2 gene induction, EC50=0.12 μM 18029176
HEK293 cells Function assay Agonist activity at PPARgamma in HEK293 cells by GAL4 transactivation assay, EC50=0.045 μM 18291645
HepG2 cells Function assay Agonist activity at human PPARalpha ligand binding domain expressed in human HepG2 cells co-transfected with Gal4 by luciferase reporter gene assay, EC50=0.039 μM 18835719
RAW264.7 cells Function assay Suppression of LPS/IFN-gamma-stimulated NO production in mouse RAW264.7 cells, EC50=17.5 μM 18809325
BL21 cells Function assay Displacement of radio labeled 2(S)-(2-benzoyl-phenylamino)-3-{4-[1,1-ditritio-2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-phenyl}-propionic acid from GST-fused human PPARgamma expressed in Escherichia coli BL21 cells by scintillation proximity assay, EC50=0.45 μM 19349176
BHK21 cells Function assay Agonist activity at human PPARgamma expressed in BHK21 cells assessed as SEAP activity by luciferase reporter transactivation assay, EC50=0.45 μM 19349176
HepG2/C3A cells Function assay Activation of human PPARgamma ligand binding domain-mediated transcriptional activity in human HepG2/C3A cells co-transfected with fused Gal4-LBD by cotransfection assay, EC50=0.0038 μM 17403688
HepG2 cells Function assay Agonist activity at PPARgamma expressed in human HepG2 cells assessed as induction of receptor transactivation by reporter gene assay relative to control, EC50=0.05 μM 18625559
COS1 cells Function assay Agonist activity at human recombinant PPARgamma expressed in COS1 cells co-expressing GAL4 assessed as transcriptional activity after 48 hrs by luciferase reporter gene assay, EC50=0.02 μM 19507861
HepG2 cells Function assay Agonist activity at human PPARgamma expressed in HepG2 cells by GAL4 transactivation assay, EC50=0.223 μM 18394907
CV1 cells Function assay Agonist activity at human PPARgamma ligand binding domain expressed in african green monkey CV1 cells co-transfected with fused Gal4-DBD by transactivation assay, EC50=0.033 μM 18826205
CV1 cells Function assay Agonist activity at human PPARalpha ligand binding domain expressed in african green monkey CV1 cells co-transfected with fused Gal4-DBD by transactivation assay, EC50=3.46 μM 18826205
U2OS cells Function assay Agonist activity at human PPARgamma in U2OS cells by transactivation assay, EC50=0.02 μM 18329751
Hep G2 cells Function assay Agonist activity at human PPARgamma ligand binding domain expressed in human Hep G2 cells co-transfected with Gal4-DBD by luciferase reporter gene assay, EC50=0.04 μM 19053776
HeLa cells Function assay Agonist activity at PPARgamma ligand binding domain expressed in human HeLa cells co-transfected with Gal4-DBD assessed as transcriptional activation by Gal4 response element-driven luciferase reporter gene assay, EC50=0.015 μM 19275963
COS1 cells Function assay Agonist activity at human PPARgamma receptor expressed in african green monkey COS1 cells co-transfected with fused yeast Gal4-DBD by transactivation assay, EC50=0.02 μM 19530681
U2OS cells Function assay Agonist activity at human PPARgamma expressed in U2OS cells by luciferase transactivation assay, EC50=0.05 μM 19574056
HepG2 cells Function assay Agonist activity at GAL4-tagged human PPARgamma ligand binding domain expressed in human HepG2 cells assessed as receptor transactivation by luciferase reporter gene assay, EC50=0.039 μM 19775169
HepG2 cells Function assay Agonist activity at human PPARgamma expressed in HepG2 cells by GAL4 transactivation assay, EC50=0.223 μM 19783444
COS7 cells Function assay Agonist activity at human recombinant PPARgamma2 LBD expressed in african green monkey COS7 cells coexpressing GAL4 by luciferase reporter gene transactivation assay, EC50=0.1 μM 20138762
COS7 cells Function assay Agonist activity at human recombinant PPARgamma1 LBD expressed in african green monkey COS7 cells coexpressing GAL4 by luciferase reporter gene transactivation assay, EC50=0.03 μM 20138762
HEK cells Function assay Agonist activity at human GAL4-tagged PPARalpha chimeric receptor expressed in HEK cells by transactivation assay, EC50=10.58 μM 20299214
HEK cells Function assay Agonist activity at human GAL4-tagged PPARgamma chimeric receptor expressed in HEK cells by transactivation assay, EC50=0.035 μM 20299214
3T3L1 cells Function assay 7 days Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in lipid accumulation after 7 days by Oil red O staining 20527969
CHO-K1 cells Function assay Partial agonist activity at human PPARgamma-LBD expressed in CHO-K1 cells co-transfected with GAL4 assessed as luciferase activity by transactivation assay, EC50=0.1 μM 20527969
HEK293T cells Function assay 1 μM 24 hrs Partial agonist activity at human PPARgamma-LBD expressed in HEK293T cells assessed as induction of receptor transactivation at 1 uM after 24 hrs by luciferase reporter gene assay 21030263
CV1 cells Function assay Transactivation of Gal4-fused human PPARgamma DNA binding domain expressed in african green monkey CV1 cells by luciferase reporter gene assay, EC50=0.1 μM 21112784
HEK293 cells Function assay 16 to 20 hrs Transactivation of Gal4-fused human PPARgamma expressed in HEK293 cells after 16 to 20 hrs by luciferase reporter gene assay, EC50=0.043 μM 21128600
HepG2 cells Function assay 10 umol/L 24 hrs Increase in glucose consumption in human HepG2 cells at 10 umol/L after 24 hrs relative to control 21256748
3T3L1 cell Function assay 1 uM Induction of mouse 3T3L1 cell differentiation assessed as increase in accumulation of intracellular lipid droplet at 1 uM by Oil red O staining 21401118
CV1 cells Function assay 40 h Agonist activity at human PPARgamma-LBD expressed in CV1 cells co-transfected with Gal4 after 40 hrs by luciferase based transactivation assay, EC50=0.1 μM 21515063
HepG2 cells Function assay Agonist activity at PPARgamma receptor expressed in human HepG2 cells by PPRE-luciferase reporter gene assay, EC50=0.01 μM 21482446
HepG2 cells Function assay Transactivation of human PPARgamma expressed in human HepG2 cells co-transfected with PPRE3-TK-Luc by luciferase reporter gene assay, EC50=0.05 μM 21450468
COS7 cells Function assay Modulation of human PPARgamma-LBD expressed in african green monkey COS7 cells co-transfected with Gal4 assessed as activation of transactivation activity by luciferase assay, EC50=0.043 μM 21873070
COS-1 cells Function assay 24 hrs Agonist activity at human PPARgamma ligand binding domain expressed in COS-1 cells after 24 hrs by luciferase reporter gene-based luminometric analysis, EC50=0.048 μM 22051054
COS1 cells Function assay 24 hrs Transactivation of human full length PPARgamma expressed in COS1 cells co-transfected with RXRalpha after 24 hrs by luciferase reporter gene assay, EC50=0.12 μM 22197396
MG-63 cells Function assay Agonist activity at human PPARgamma expressed in MG-63 cells by reporter gene-based transactivation assay, EC50=0.011 μM 22225641
COS1 cells Function assay Binding affinity to human wild type PPARgamma LBD expressed in COS1 cells co-expressing GAL4 by scintillation proximity assay 22070604
MG-63 cells Function assay 24 hrs Modulation of full-length human pSG5-fused PPARgamma expressed in MG-63 cells co-expressing pGV-P2-PPRE after 24 hrs by luciferase reporter gene based transactivation assay, EC50=0.011 μM 22727448
Ac2F cells Function assay 0.1 to 10 μM 6 hrs Agonist activity at PPARgamma in rat Ac2F cells assessed as luciferase activity at 0.1 to 10 uM after 6 hrs by reporter gene assay 22819190
293H DA cells Function assay 16 h Agonist activity at PPARgamma LBD in human 293H DA cells after 16 hrs by TR-FRET activation reporter assay, EC50=0.0024 μM 22582973
3T3L1 cells Function assay 10 uM Increase in adiponectin mRNA levels in TNFalpha-induced mouse 3T3L1 cells pretreated at 10 uM before TNF-alpha challenge relative to control 21851089
HepG2 cells Function assay 10 uM 24 h Reduction of glucose consumption in insulin-resistant human HepG2 cells at 10 uM after 24 hrs by glucose oxidase method in presence of 22.2 mM of glucose 23025244
HepG2 cells Function assay 10 uM 24 h Reduction of glucose consumption in insulin-resistant human HepG2 cells at 10 uM after 24 hrs by glucose oxidase method in presence of 0.1 uM of insulin 23025244
THP1 cells Function assay 100 uM 3 hrs Transactivation of PPARgamma in human THP1 cells assessed as decrease in LPS-induced MCP1 mRNA expression at 100 uM preincubated for 3 hrs prior to LPS challenge measured after 18 hrs by RT-PCR analysis relative to untreated control 22934537
THP1 cells Function assay 100 uM 3 hrs Transactivation of PPARgamma in human THP1 cells assessed as decrease in LPS-induced IL6 mRNA expression at 100 uM preincubated for 3 hrs prior to LPS challenge measured after 18 hrs by RT-PCR analysis relative to untreated control 22934537
HepG2 cells Function assay Transactivation of GAL4-fused PPARgamma ligand binding domain transfected in human HepG2 cells by luciferase reporter gene assay, EC50=0.1 μM 22934537
HepG2 cells Function assay 20 h Agonist activity at human GAL4-fused PPARgamma ligand binding domain expressed in HepG2 cells after 20 hrs by luciferase reporter gene transactivation assay, EC50=0.02 μM 22081932
BL21 DE3 cells Function assay Displacement of [3H]rosiglitazone from N-terminal His-tagged human PPARgamma ligand binding domain expressed in Escherichia coli BL21 DE3 cells by scintillation proximity assay, Ki=0.074 μM 22081932
human L02 cells Function assay Agonist activity at PPARgamma-LBD expressed in human L02 cells co-expressing pGL3-SV40-GAL4 after 24 hrs by luciferase reporter gene based transactivation assay, EC50=0.9 μM 23186307
HepG2 cells Function assay 20 h Transactivation of GAL4-fused human PPARgamma ligand binding domain expressed in HepG2 cells after 20 hrs by luciferase reporter gene assay, EC50=0.039 μM 23171045
HEK293 cells Function assay 10 μM Transactivation of PPARgamma (unknown origin) expressed in HEK293 cells co-transfected with AP2-PPRE at 10 uM by luciferase reporter gene assay 23273519
HEK293 cells Function assay Agonist at human PPARgamma LBD expressed in human HEK293 cells cotransfected with GAL4-Luc assessed as transcriptional activation by luciferase reporter gene assay, EC50=0.004 μM 23286787
HEK293 cells Function assay 24 h Transactivation of GAL4 DBD-fused human PPARgamma-LBD expressed in HEK293 cells after 24 hrs by luciferase reporter gene assay, EC50=0.1 μM 23294830
HEK293 cells Function assay 48 hrs Agonist activity at human PPARgamma expressed in HEK293 cells cotransfected with PPREx4-TK-luc assessed as activation of luciferase activity measured after 48 hrs by transactivation assay, EC50=43.71 μM 23265844
HepG2 cells Function assay Agonist activity at GAL4-fused PPARgamma (unknown origin) expressed in human HepG2 cells by transactivation assay, EC50=0.01 μM 23502212
HepG2 cells Function assay Agonist activity at GAL4-fused PPARgamma M463A mutant (unknown origin) expressed in human HepG2 cells by transactivation assay, EC50=0.002 μM 23502212
L6 cells Function assay 24 hrs Induction of glucose uptake in rat L6 cells pulsed with C14-deoxy glucose after 24 hrs in presence of insulin, EC50=4.49 μM 23992862
L6 cells Function assay 16 hrs Increase in 2-[3H]-deoxyglucose uptake in rat L6 cells after 16 hrs by scintillation counting analysis, EC50=4.8 μM 24813738
DU145 cells Cytotoxicity assay 48 hrs Cytotoxicity against human DU145 cells assessed as growth inhibition after 48 hrs by MTT assay, EC50=16 μM 24996143
PC3 cells Cytotoxicity assay 48 hrs Cytotoxicity against human PC3 cells assessed as growth inhibition after 48 hrs by MTT assay, EC50=20.3 μM 24996143
MDA-MB-231 cells Growth inhibition assay 24 hrs Growth inhibition of human MDA-MB-231 cells after 24 hrs by MTT assay, EC50=5.23 μM 25278236
HEK293 cells Function assay Agonist activity at human PPARgamma expressed in HEK293 cells by luciferase reporter gene assay, EC50=0.01 μM 25305688
HepG2 cells Function assay 20 hrs Transactivation of PPAR transfected in human HepG2 cells after 20 hrs by PPAR-luciferase assay, EC50=1.6 μM 25437304
HEK293 cells Function assay 24 hrs Transactivation of PPARgamma (unknown origin) expressed in HEK293 cells incubated for 24 hrs by luciferase reporter gene assay 25442322
HepG2 cells Function assay Agonist activity at human GAL4-PPARgamma ligand binding domain expressed in human HepG2 cells by luciferase reporter gene assay, EC50=0.039 μM 25462281
HEK293 cells Function assay 24 hrs Agonist activity at mouse PPARgamma expressed in HEK293 cells co-expressing with Gal4 reporter vector after 24 hrs by dual-luciferase reporter assay, EC50=0.03 μM 24955889
HepG2 cells Function assay 20 hrs Agonist activity at GAL4-DNA binding domain fused human PPARgamma ligand binding domain expressed in human HepG2 cells assessed as receptor transactivation incubated for 20 hrs by luciferase reporter gene assay, EC50=0.04 μM 25497132
HepaR cells Function assay 1 day Agonist activity at PPARgamma in human HepaR cells assessed as increase in HMGCS2 gene expression at 1 uM incubated for 1 day by quantitative PCR method relative to untreated control 25497132
HepaR cells Function assay 1 uM 1 day Agonist activity at PPARgamma in human HepaR cells assessed as increase in ANGPTL4 gene expression at 1 uM incubated for 1 day by quantitative PCR method relative to untreated control 25497132
HepaR cells Function assay 1 uM 1 day Agonist activity at PPARgamma in human HepaR cells assessed as increase in FABP1 gene expression at 1 uM incubated for 1 day by quantitative PCR method relative to untreated control 25497132
HEK293 cells Function assay 10 μM 24 hrs Transactivation of PPAR-gamma (unknown origin) expressed in HEK293 cells at 10 uM after 24 hrs by luciferase reporter gene assay 24890090
C2C12 cells Function assay 30 μM 2 h Induction of 2-deoxy-[3H]-glucose uptake in mouse C2C12 cells at 30 uM after 2 hrs by liquid scintillation counting analysis 25835537
MCF7 cells Function assay 16 h Agonist activity at human PPARgamma transfected in human MCF7 cells after 16 hrs by luciferase reporter gene assay, EC50=0.087 μM 26226490
HEK293 cells Function assay 10 μM 24 h Agonist activity at PPARgamma (unknown origin) expressed in HEK293 cells assessed as receptor transactivation at 10 uM incubated for 24 hrs by luciferase reporter gene assay 26384286
Click to View More Cell Line Experimental Data

Biological Activity

Description 4-Methylumbelliferone is a hyaluronic acid (HA) synthesis inhibitor with an IC50 of 0.4 mM.
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05295680 Recruiting
Primary Sclerosing Cholangitis
Aparna Goel|Stanford University
 May 10 2023 Phase 2

Chemical Information & Solubility

Molecular Weight 176.17 Formula

C10H8O3
CAS No. 90-33-5 SDF Download 4-Methylumbelliferone (4-MU) SDF
Smiles CC1=CC(=O)OC2=C1C=CC(=C2)O
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 35 mg/mL ( (198.67 mM)； Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 35 mg/mL

Water : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy 4-Methylumbelliferone (4-MU) | 4-Methylumbelliferone (4-MU) supplier | purchase 4-Methylumbelliferone (4-MU) | 4-Methylumbelliferone (4-MU) cost | 4-Methylumbelliferone (4-MU) manufacturer | order 4-Methylumbelliferone (4-MU) | 4-Methylumbelliferone (4-MU) distributor